Iterum Therapeutics plc Announces Petition for Winding Up and Appointment of Joint Provisional Liquidators
DUBLIN and CHICAGO, March 27, 2026 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (in Provisional Liquidation) (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has filed a…

